Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/19181929

Download in:

View as

General Info

PMID
19181929